Covered recipient · General Payments record
JONATHAN BARAK FASS
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$2,419.49
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $357.43 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $155.85 | 8 |
| PFIZER INC. | $78.33 | 5 |
| Janssen Biotech, Inc. | $40.00 | 1 |
| Regeneron Healthcare Solutions, Inc. | $26.30 | 1 |
| Lilly USA, LLC | $20.66 | 1 |
| UCB, Inc. | $18.38 | 1 |
| GENZYME CORPORATION | $17.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.51 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103714231 | CMS |
| ABBVIE INC. | $21.66 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103714233 | CMS |
| ABBVIE INC. | $19.72 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103714235 | CMS |
| ABBVIE INC. | $10.27 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103714237 | CMS |
| ABBVIE INC. | $26.66 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103714239 | CMS |
| ABBVIE INC. | $25.29 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103714241 | CMS |
| ABBVIE INC. | $17.87 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103714243 | CMS |
| ABBVIE INC. | $23.87 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103714245 | CMS |
| GENZYME CORPORATION | $17.91 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139667694 | CMS |
| Janssen Biotech, Inc. | $40.00 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078540362 | CMS |
| Lilly USA, LLC | $20.66 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135078119 | CMS |
| PFIZER INC. | $14.26 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131558776 | CMS |
| PFIZER INC. | $19.63 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131658419 | CMS |
| PFIZER INC. | $14.39 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131768765 | CMS |
| PFIZER INC. | $14.85 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131755202 | CMS |
| PFIZER INC. | $15.20 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132127057 | CMS |
| Regeneron Healthcare Solutions, Inc. | $26.30 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114045862 | CMS |
| UCB, Inc. | $18.38 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143285678 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.